SCHEMBL3678643

SCHEMBL3678643

CCCCCCCCCC(=O)ON1C(=O)c2ccccc2C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ASAH1 Q13510 1/20 0.50
POLM Q9NP87 2/20 0.48
POLK Q9UBT6 2/20 0.48
POLL Q9UGP5 2/20 0.48
POLH Q9Y253 2/20 0.48
ALDH1A1 P00352 2/20 0.46
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
HPSE Q9Y251 1/20 0.44
CES1 P23141 3/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CES2 O00748 1/20 0.43
MEN1 O00255 1/20 0.43
HSD17B10 Q99714 1/20 0.43
SOAT1 P35610 2/20 0.43
HPGD P15428 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CDC25A P30304 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678825 1.00 ASAH1 (0.50) ASAH1POLMPOLKPOLLPOLH
SCHEMBL2040524 1.00 ASAH1 (0.50) ASAH1POLMPOLKPOLLPOLH
SCHEMBL3678799 1.00 ASAH1 (0.50) ASAH1POLMPOLKPOLLPOLH
SCHEMBL3679722 1.00 ASAH1 (0.50) ASAH1POLMPOLKPOLLPOLH
SCHEMBL1537374 1.00 ASAH1 (0.50) ASAH1POLMPOLKPOLLPOLH
SCHEMBL3676598 0.98 ASAH1 (0.48) ASAH1POLMPOLKPOLLPOLH
SCHEMBL1537373 0.94 ALDH1A1 (0.48) ASAH1POLMPOLKPOLLPOLH
SCHEMBL4311303 0.88 TDP1 (0.60) POLMPOLKPOLLPOLHALDH1A1
SCHEMBL3678891 0.87 ALDH1A1 (0.50) ASAH1ALDH1A1CES1KMT2AMEN1
SCHEMBL6444162 0.87 PTPN7 (0.47) ASAH1POLMPOLKPOLLPOLH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7741514-B2 Catalyst comprising N-substituted cyclic imide compound and process for producing organic compound using the catalyst DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-22 US disclosed
US-20060281629-A1 Catalyst comprising N-substituted cyclic imide compound and process for producing organic compound using the catalyst ISHII YASUTAKA 2006-12-14 US disclosed
US-7115541-B2 Catalyst comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalyst DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2006-10-03 US disclosed
EP-1338336-A1 CATALYSTS COMPRISING N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS Daicel Chemical Industries, Ltd. (JP) 2003-08-27 EP disclosed
US-20030013603-A1 Catalyst comprising n-substituted cylic imides and processes for preparing organic compounds with the catalyst DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281629-A1 Catalyst comprising N-substituted cyclic imide compound and process for producing organic compound using the catalyst NOS2, NOS1, NOS3 ASAH1 2052/4885POLM 461/4885POLK 3090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.